首页> 外文期刊>Hepato-gastroenterology. >Comparison of Short- and Long-Term Outcomes of an Early Experience with Robotic and Laparoscopic-Assisted Resection for Rectal Cancer
【24h】

Comparison of Short- and Long-Term Outcomes of an Early Experience with Robotic and Laparoscopic-Assisted Resection for Rectal Cancer

机译:机器人和腹腔镜辅助切除术治疗直肠癌的早期经验的短期和长期结果比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Robotic surgery is increasingly used for rectal cancer. We compared the short- and long-term outcomes between robotic- and laparoscopic-assisted resection for rectal cancer. Methodology: A retrospective chart review was performed between 2006 and 2010. Results: Seventeen robotic and 61 laparoscopic surgeries were performed consecutively. Median follow-up time was 58.2 months. No operation was converted to open surgery. No difference was observed between the groups for types of operations, diverting ileostomy rate, operation time, blood loss, and postoperative hospital stay, tumor diameter, distal margin, circumferential margin, tumor stage, differentiation, lymphovascular, or perineural invasion. However, the number of harvested lymph nodes was higher in the robot than that in the laparoscopy group (p = 0.017). Overall morbidity and reoperation rates were similar between the groups. The 5-yr overall and disease-free survival rates of all patients were 82.5% and 81.3%; respectively. The 5-yr overall and disease-free survival rates of the robotic and the laparoscopy groups were 94.1% and 79.7% (p = 0.241), and 94.1% and 77.9% (p = 0.159), respectively. Conclusions: Robot-assisted resection for rectal cancer resulted in harvesting more lymph nodes without increasing morbidity and showed a comparable survival rate, compared with those of laparoscopy.
机译:背景/目的:机器人手术越来越多地用于直肠癌。我们比较了机器人和腹腔镜辅助切除直肠癌之间的短期和长期结果。方法:对2006年至2010年进行回顾性图表审查。结果:连续进行了17例机器人手术和61例腹腔镜手术。中位随访时间为58.2个月。没有手术被改成开腹手术。两组之间在手术类型,回肠造瘘率,手术时间,失血量和术后住院时间,肿瘤直径,远端边缘,圆周边缘,肿瘤分期,分化,淋巴血管或神经周浸润等方面没有差异。但是,机器人采集的淋巴结数目要比腹腔镜检查组高(p = 0.017)。两组之间的总发病率和再次手术率相似。所有患者的5年总生存率和无病生存率分别为82.5%和81.3%;分别。机器人组和腹腔镜组的5年总生存率和无病生存率分别为94.1%和79.7%(p = 0.241),94.1%和77.9%(p = 0.159)。结论:与腹腔镜手术相比,机器人辅助手术切除直肠癌可收获更多的淋巴结而不会增加发病率,并且具有相当的生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号